=> [Français]
=> [Português]

Database - Alliance francophone pour l'accouchement respecté (AFAR)

Record ID : 860
Created on : 27/07/2004
Modified on : 27/12/2007

Modify this record
Do not follow this link unless you know the admin password!

URL of this record : http://afar.info/id=860

=> hard

Author(s) :

Philip J, Silver RK, Wilson RD, Thom EA, et al.

Year of publication :

2004

Bibliographical entry (without author) :

Late first-trimester invasive prenatal diagnosis: results of an international randomized trial.
Obstet Gynecol. 2004 Jun;103(6):1164-73.

Résumé (français) :

Abstract (English):

OBJECTIVE: To assess, in a randomized trial, the safety and accuracy of amniocentesis and transabdominal chorionic villus sampling (CVS) performed at 11-14 weeks of gestation, given that this time frame is increasingly relevant to early trisomy screening.

METHODS: We compared amniocentesis with CVS from 77 to 104 days of gestation in a randomized trial in a predominantly advanced maternal age population. Before randomization, the feasibility of both procedures was confirmed by ultrasonography, and experienced operators performed sampling under ultrasound guidance; conventional cytogenetic analysis was employed. The primary outcome measure was a composite of fetal loss plus preterm delivery before 28 weeks of gestation in cytogenetically normal pregnancies.

RESULTS: We randomized 3,775 women into 2 groups (1,914 to CVS; 1,861 to amniocentesis), which were comparable at baseline. More than 99.6% had the assigned procedure, and 99.9% were followed through delivery. In contrast to previous thinking, in the cytogenetically normal cohort (n = 3,698), no difference in primary study outcome was observed: 2.1% (95% confidence interval 1.5, 2.8) for CVS and 2.3% (95% confidence interval, 1.7, 3.1) for amniocentesis. However, spontaneous losses before 20 weeks and procedure-related, indicated terminations combined were increased in the amniocentesis group (P =.07, relative risk 1.74). We found a 4-fold increase in the rate of talipes equinovarus after amniocentesis (P =.02) overall and in week 13 (P =.03, relative risk = 4.65), but data were insufficient to determine this risk in week 14.

CONCLUSION: Amniocentesis at 13 weeks carries a significantly increased risk of talipes equinovarus compared with CVS and also suggests an increase in early, unintended pregnancy loss.

LEVEL OF EVIDENCE: I

Sumário (português):

URL :

http://www.greenjournal.org/cgi/content/abstract/103/6/1164

Comments :

Argument (français) :

L'amniocentèse pendant le 1er trimestre de grossesse entraîne un risque de pied bot 4 fois plus élevé que le prélèvement des villosités choriales.

Argument (English):

Argumento (português):

Keywords :

amniocentesis ; screening ; evidence-based medicine/midwifery ; stillbirth ; maternal age ; trisomy

Author of this record :

C. Loup

New expert query ---  New simple query

Creating new record --- Importing records

This database is managed by Alliance francophone pour l'accouchement respecté (AFAR, http://afar.info)
affiliated with Collectif interassociatif autour de la naissance (CIANE, http://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) becoming a member of AFAR
(2) financially supporting AFAR
(3) contributing to this database if you have a minimum training in scientific documentation.